Back to Search Start Over

Supplementary Table S2 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

Authors :
Yi-Long Wu
Andreas Johne
Rolf Bruns
Karin Berghoff
Jun Zhao
Yiping Zhang
James Chih-Hsin Yang
Sang Won Shin
Shun Lu
Ying Cheng
Ross Andrew Soo
Dong-Wan Kim
Jianying Zhou
Te-Chun Hsia
Azura Rozila Ahmad
Chong Kin Liam
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Representativeness of study population

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....80a394bfe0e9c134b3c5f2a22777c1b6